By the end of the year 30 analysts had handed down opinions on Hannover Re: three analysts (nine) recommended the Hannover Re share as “buy” or “overweight”. Altogether 17 opinions (18) were a “hold”, making this the most common. “Underweight” or “sell” recommendations were issued a total of ten (five) times. The analysts’ average price target continued to move higher in the year under review from EUR 110.49 at the start of the financial year to EUR 116.20 at yearend. This development is particularly pleasing in view of what is still a relatively superior valuation measured against peer companies.